Study 1 of 12 for search of: basal cell carcinoma and hedgehog
Previous Study Return to Search Results Next Study

Full Text View
Tabular View
Study Results
Related Studies
A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma
This study is ongoing, but not recruiting participants.
Study NCT00833417   Information provided by Genentech

First Received on January 30, 2009.   Last Updated on March 1, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Basal Cell Carcinoma
Additional conditions recognized in this trial
Carcinoma
Carcinoma, Basal Cell
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Basal Cell
Neoplasms, Glandular and Epithelial
Interventions listed in this trial
Vismodegib 150 mg
Sponsors listed in this trial
Genentech


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services